Member States gathered at the first intersessional since the 57th Session of the Commission on Narcotic Drugs to discuss issues related to UNGASS, law enforcement, HIV prevention and demand reduction, etc. A summary of the discussions is available below. Agenda item 1 – Consideration of Resolution 57/5 on UNGASS Chair. The chair urged civil society …
Canada
Committee of the Whole – Final Debate on UNGASS Resolution Article 6bis
Alt 6 bis. Further decides that the Commission on Narcotic Drugs, as the central policymaking body of the UN system, dealing with drug related matters shall lead this process, by addressing all organizational and substantive matters in open ended manner and in this regard invites the president of the General Assembly in this regard to …
UNGASS resolution deadlock
Chair – L2 – L14, except the one on UNGASS preparation L10. Special session of the General Assembly on the world drug problem to be held in 2016 E/CN.7/2014/L.10 Chair of CND takes over as Chair of Cow: Ambassador Shamaa There has been extensive discussions on this text. There has been a lot of work in informal and formals …
Committee of the Whole – E/CN.7/2014/L.5
Raising awareness and strengthening internationalcooperation in combating drug trafficking in opiates which misuses trade inopium poppy seeds Germany. 3 different resolution. Cannot take this and cannot examine without electronic copy. This is a very changed resolution from the beginning. We can’t get approval from capital. Title…should be as follows. Raising awareness and strengthening international cooperation …
Committee of the Whole E/CN.7/2014/L.9 (revisited)
PP? Russia: there is no notion of stigma, it’s not scientifically evidence based. Must delete stigma Chair: this has already been decided by COW Russia: No. We have nothing in legislation. UK: It was agreed by COW. This is common UNODC language. Previously Russia had agreed to the language Australia: there is a scientific base …
Best Practices in the use of cannabis for medical purposes.
This event was chaired by Dr. Franz Pietsch. Federal Ministry of Health, Austria and Professor Mark Ware, McGill University, Canada. Issues in cannabinoid prescribing Costs Off label use Stigma of cannabis still present Typically considered third or fourth line option – ie for chronic pain Abuse potential low See: Ware and St. Arnaud (Addiction 2010) …